LACOUS MIRA K 4

What Happened

• Mira K. Lacous, Chief Technology Officer of BIO-key International, received/acquired 250 shares (transaction code A) on June 30, 2026. The reported per-share price was $3.83, for a total value of approximately $958. This was an acquisition under an employee plan rather than a market purchase or sale.

Key Details

• Transaction date and price: 2026-06-30, 250 shares at $3.83 each.
• Total value: approximately $958.
• Filing date / timeliness: Form 4 filed 2026-07-02; no late-filing (“L”) indication provided in the filing.
• Shares owned after transaction: not disclosed in the information provided in this summary/filing.
• Footnotes:
  • F1: Shares acquired under the BIO-key 2021 Employee Stock Purchase Plan; the transaction was exempt under Rule 16b-3(d) and 16b-3(c).
  • F2: All share amounts reflect BIO-key’s 1-for-10 reverse stock split, effective April 30, 2026.

Context

• This was an employee-plan acquisition (award/purchase), which insiders commonly receive as part of compensation—small-dollar employee purchases are routine and don’t by themselves signal a major change in insider sentiment.
• Purchases or awards are generally more informative than sales, but this single small award (~$958) should be viewed as routine compensation unless accompanied by other trading activity.